Total 13
| Number | Title | Date |
| 13 |
Abion CEO Shin Young Kee “Vabametkib and Lazertinib combination cohort filling for 3Q”
|
2024.10.16
|
2024.10.16 |
| 12 |
ABION Vice President Choi Jun-young: “AI-enhanced MET CTC test ensures fast and accurate lung cancer screening”
|
2024.10.16
|
2024.10.16 |
| 11 |
[ESMO 2024] Abion Poster Presentation
|
2024.10.16
|
2024.10.16 |
| 10 |
Abion signed agreement with Johnson & Johnson on drug supply for combination clinical trial
|
2024.06.28
|
2024.06.28 |
| 9 |
[ASCO 2024] Abion Presentation
|
2024.06.04
|
2024.06.04 |
| 8 |
[AACR 2024] ABN 501 Poster
|
2024.05.03
|
2024.05.03 |
| 7 |
[AACR 2024] ABN 202 Poster[TROP2]
|
2024.05.03
|
2024.05.03 |
| 6 |
[AACR 2024] ABN 202 Poster[VISTA]
|
2024.05.03
|
2024.05.03 |
| 5 |
[AACR 2024] ABN 202 Poster[EGFR]
|
2024.05.03
|
2024.05.03 |
| 4 |
Cambrian explosion of ADCs at AACR24
|
2024.04.23
|
2024.04.23 |
| 3 |
[2024 PEPTALK] Abion ABN 101 Presentation Abstract
|
2024.01.29
|
2024.01.29 |
| 2 |
Notice to Investors and Shareholders
|
2024.01.28
|
2024.01.28 |
| 1 |
2023 ABN401 SHOWCASE
|
2023.10.20
|
2023.10.20 |
